All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cance, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
Optimising positioning for infants born with Congenital Diaphragmatic Hernia
Using Electrical Impedance Tomography to Evaluate the Effect of Positioning in Neonates with Congenital Diaphragmatic Hernias.
PACIFIC-9
A Phase III, double-blind, placebo-controlled, Randomised, Multicentre, International Study of Durvalumab Plus Oleclumab and Durvalumab Plus Monalizumab in Patients With Locally Advanced (Stage III), Unresectable Non-small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Definitive, Platinum-Based Concurrent Chemoradiation Therapy.
Palekona - An oral treatment for Ulcerative Colitis
Study of GS-5290 in participants with moderately to severely active ulcerative colitis
PARAGON-II
This trial is for people with gynaecological cancers whose tumours are potentially treatable with endocrine treatment.
Phenylketonuria (PKU): An early phase trial of a new treatment for PKU
This study is trialing a novel drug, called JNT-517, which works by increasing excretion of phenylalanine in the urine to reduce circulating levels in the blood.
Pilaster - New add on therapy to help treat chronic obstructive pulmonary disease with chronic bronchitis
Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With Chronic obstructive pulmonary disease (COPD) and Chronic Bronchitis.
PUERTA: A novel treatment for patients in acute respiratory distress
ALT-100-002: Pioneering the Utility of eNAMPT-Reducing Therapies in Acute Respiratory Distress Syndrome [ARDS]/ ventilator-induced lung injury.
QUASAR Jr
The purpose of this study is to evaluate the effectiveness of guselkumab in pediatric participants with moderately to severely active ulcerative colitis through open label induction and through maintenance therapy among participants who were induction responders.
RAISE A clinical trial of a ganaxalone in status epilepticus
RC-48
The trial is testing a potential new treatment called disitamab vedotin for Muscle-invasive Bladder Cancer.